APPLICATION OF NEURAL COMPUTING IN PHARMACEUTICAL PRODUCT DEVELOPMENT

被引:130
作者
HUSSAIN, AS
YU, XQ
JOHNSON, RD
机构
[1] The Division of Pharmaceutics and Drug Delivery Systems, College of Pharmacy, University of Cincinnati-Medical Center, Cincinnati, Ohio
关键词
NEURAL COMPUTING; ARTIFICIAL NEURAL NETWORKS; PHARMACEUTICAL FORMULATION; RESPONSE SURFACE METHODOLOGY; CONTROLLED RELEASE; CAPSULES;
D O I
10.1023/A:1015843527138
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Neural computing technology is capable of solving problems involving complex pattern recognition. This technology is applied here to pharmaceutical product development. The most commonly used computational algorithm, the delta back-propagation network, was utilized to recognize the complex relationship between the formulation variables and the in vitro drug release parameters for a hydrophilic matrix capsule system. This new computational technique was also compared with the response surface methodology (RSM). Artificial neural network (ANN) analysis was able to predict the response values for a series of validation experiments more precisely than RSM. ANN may offer an alternative to RSM because it allows for the development of a system that can incorporate literature and experimental data to solve common problems in the pharmaceutical industry.
引用
收藏
页码:1248 / 1252
页数:5
相关论文
共 22 条
[1]  
BAFFES PT, 1989, COSMIC
[2]  
BHAGAT P, 1990, CHEM ENG PROG, V86, P55
[3]  
Box GEP, 1986, EMPIRICAL MODEL BUIL
[4]  
CORNELL JA, 1981, EXPT MIXTURES DESIGN
[5]   MATHEMATICAL OPTIMIZATION TECHNIQUES IN DRUG PRODUCT DESIGN AND PROCESS ANALYSIS [J].
FONNER, DE ;
BUCK, JR ;
BANKER, GS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (11) :1587-+
[6]  
FRANZ R M, 1987, Journal of Controlled Release, V5, P159, DOI 10.1016/0168-3659(87)90007-1
[7]  
GOUND PL, 1984, INT J PHARM TECH PRO, V5, P19
[8]  
GROSSBERG S, 1982, STUDIES MIND BRAIN N
[9]   OPTIMIZATION OF A SLOW-RELEASE TABLET FORMULATION CONTAINING SODIUM SULFATHIAZOLE AND A MONTMORILLONITE CLAY [J].
HARRIS, MR ;
SCHWARTZ, JB ;
MCGINITY, JW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1985, 11 (05) :1089-1110
[10]  
HEBB DO, 1949, ORG BEHAVIOR